JSR logo

JSR

Asia, Tokyo, Japan, Tokyo

Description

JSR creates and supplies materials used in the manufacture of semiconductor chips.

Investor Profile

JSR has made 16 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (25%)
  • Series D (25%)
  • Series C (19%)
  • Series Unknown (19%)
  • Series E (6%)
  • Series A (6%)

Country Focus

  • United States (88%)
  • United Kingdom (6%)
  • India (6%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Semiconductor
  • Medical
  • 3d Printing
  • 3d Technology
  • Hardware
  • Product Design
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JSR frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Next Play Capital
North America, California, United States, Redwood City
Co-Investments: 2
Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 3
Applied Ventures
North America, California, United States, Santa Clara
Co-Investments: 2
Shumway Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Air Liquide ALIAD
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
H
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does JSR often collaborate with?

EA
Europe, Overijssel, The Netherlands, Zwolle
Shared Deals: 1
Kevin F. Li
North America, Canada
Shared Deals: 1

What are some of recent deals done by JSR?

Cropin

Bengaluru, Karnataka, India

Cropin is an AI and data-led agri-tech​ organization that provides SaaS solutions to agribusinesses globally using deep learning.

AgTechArtificial Intelligence (AI)Cloud Data Services
Series DDec 9, 2022
Amount Raised: $13,755,442
Fluence Analytics

New Orleans, Louisiana, United States

Fluence Analytics is a manufacturer of industrial and laboratory systems.

ChemicalDeveloper PlatformManufacturing
Series UnknownAug 16, 2021
Amount Raised: $7,500,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series DJul 21, 2021
Amount Raised: $68,000,000
Iridia

Carlsbad, California, United States

Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.

Data StorageElectronicsHealth CareSemiconductor
Series BMar 16, 2021
Amount Raised: $24,000,000
AlphaICs

Milpitas, California, United States

AlphaICs is advancing AI compute with its patented technology called RAP.

Artificial Intelligence (AI)Cloud ComputingComputerSemiconductor
Series BJan 20, 2021
Amount Raised: $8,000,000
Cambridge Quantum Computing

Cambridge, Cambridgeshire, United Kingdom

CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms.

Artificial Intelligence (AI)ComputerEnterprise SoftwareQuantum Computing
Series UnknownDec 8, 2020
Amount Raised: $45,000,000
Inpria

Corvallis, Oregon, United States

Inpria Corporation extends semiconductor lithography with inorganic photoresists and other thin films for nanoscale patterning.

ElectronicsManufacturingSemiconductor
Series CFeb 21, 2020
Amount Raised: $31,000,000
Carbon

Redwood City, California, United States

Carbon is a company that provides high-tech, waste reducing 3D printing services.

3D Printing3D TechnologyHardwareManufacturingProduct Design
Series EJun 25, 2019
Amount Raised: $260,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series CMay 13, 2019
Amount Raised: $18,500,000
Absci

Vancouver, Washington, United States

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science
Series DJan 7, 2019
Amount Raised: $10,360,013